Found: 7
Select item for more details and to access through your institution.
Targeting protein folding in N‐Myc‐driven medulloblastoma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 387, doi. 10.1002/1878-0261.13395
- By:
- Publication type:
- Article
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 226, doi. 10.1093/neuonc/noaa191
- By:
- Publication type:
- Article
MEDU-01. HDACi AND PLK1i ACT SYNERGISTICALLY IN MYC-AMPLIFIED MEDULLOBLASTOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii103, doi. 10.1093/neuonc/noz036.161
- By:
- Publication type:
- Article
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 168, n. 2, p. 317, doi. 10.1007/s11060-024-04672-9
- By:
- Publication type:
- Article
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 617, doi. 10.1007/s11060-023-04445-w
- By:
- Publication type:
- Article
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 163, n. 1, p. 143, doi. 10.1007/s11060-023-04319-1
- By:
- Publication type:
- Article
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 4, p. 735, doi. 10.1093/neuonc/noac199
- By:
- Publication type:
- Article